PMC4860985_01
Amniotic membrane transplantation (AMT) in case #3. The photographs show progression of treatment : (a) Preoperatively; (b) immediately after the operation; (c) 3 months after surgery; (d) 24 months post-operation; (e) general appearance two years after transplantation.
JOVR-11-37-g002.jpg
PMC4860985_01_JOVR-11-37-g002.jpg
F1
She received sensitivity-confirmed ceftazidime and amikacin eye drops every one hour for one week [Figure 1a]. OCT three months and one year after surgery, and pachymetry one year after surgery showed remarkable healing [Figures 1 and 2].
Amniotic membrane transplantation (AMT) in case #3. (a) Optical coherence tomography (OCT) image three months postoperatively; (b) OCT and (c) pachymetry one year after surgery show nearly complete anatomical repair of the cornea.
JOVR-11-37-g003.jpg
PMC4860985_01_JOVR-11-37-g003.jpg
F2
OCT three months and one year after surgery, and pachymetry one year after surgery showed remarkable healing [Figures 1 and 2].
PMC4860985_02
Amniotic membrane transplantation in case #4. Progression of treatment: (a) Preoperative appearance; (b)immediately following the operation; (c) three months post operation; (d) 24 months after surgery; (e) general appearance 24 months post-operatively.
JOVR-11-37-g004.jpg
PMC4860985_02_JOVR-11-37-g004.jpg
F3
Improvement in corneal thickness and integrity was evident on OCT three and 24 months following surgery, and on Orbscan 24 months after the operation [Figures 3 and 4].
Amniotic membrane transplantation in case #4. (a) Optical coherence tomography (OCT) 3 months after the operation; (b) OCT 24 months post-operatively; (c) anterior (C) and posterior (d) corneal surface depicted by Orbscan two years after surgery; both imaging modalities show significant amelioration of the Descemetocele.
JOVR-11-37-g005.jpg
PMC4860985_02_JOVR-11-37-g005.jpg
F4
Improvement in corneal thickness and integrity was evident on OCT three and 24 months following surgery, and on Orbscan 24 months after the operation [Figures 3 and 4].